The researchers note that the cardiovascular benefits and safety of SGLT-2 inhibitors have primarily been studied in placebo-controlled trials, leaving the comparative effectivene ...
The past 20 years have witnessed remarkable progress in the evolution of transcatheter procedures for the treatment of adult patients with congenital heart disease. In this Review, Rodés-Cabau ...